|
|||||
|
|
New and emerging biologic therapies for moderate‐to‐severe plaque psoriasis: mechanistic rationales and recent clinical data for IL‐17 and IL‐23 inhibitors |
|
| Authors: | Anthony A. Gaspari Stephen Tyring |
| Affiliation: | 1. Department of Dermatology, University of Maryland Medical Center, Baltimore, Maryland;2. Department of Dermatology, University of Texas Health Science Center, Houston, Texas |
| Abstract: | |
| Keywords: | biologic interleukin‐17 interleukin‐23 psoriasis |